Cancer Letters
Volume 291, Issue 2 , Pages 187-199 , 28 May 2010

Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells

  • Wei Ney Yap

      Affiliations

    • Davos Life Science Pte. Ltd., Cancer Research Laboratory, 16 Tuas South Street 5, Singapore
    • Both authors contribute equally to this study.
    • ,
  • Norazean Zaiden

      Affiliations

    • Davos Life Science Pte. Ltd., Cancer Research Laboratory, 16 Tuas South Street 5, Singapore
    • Both authors contribute equally to this study.
    • ,
  • Yee Ling Tan

      Affiliations

    • Singapore Bioimaging Consortium (SBIC), Biomedical Sciences Institutes, 11 Biopolis Way #02-02 Helios, Singapore 138667, Singapore
    • ,
  • Chang Piek Ngoh

      Affiliations

    • Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore 169857, Singapore
    • ,
  • Xue Wu Zhang

      Affiliations

    • College of Light Industry and Food Sciences, South China University of Technology, Guang Zhou, China
    • ,
  • Y.C. Wong

      Affiliations

    • Department of Anatomy, Cancer Biology Lab, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, Laboratory Block, 21 Sassoon Road, Hong Kong SAR, China
    • ,
  • M.T. Ling

      Affiliations

    • Australian Prostate Cancer Research Centre-Queensland Institute of Health and Biomedical Innovation (IHBI), QUT, Australia
    • Corresponding Author InformationCorresponding authors.
    • ,
  • Yee Leng Yap

      Affiliations

    • Davos Life Science Pte. Ltd., Cancer Research Laboratory, 16 Tuas South Street 5, Singapore
    • Corresponding Author InformationCorresponding authors.

Received 3 August 2009 ,Revised 9 October 2009 ,Accepted 15 October 2009.

References 

  1. Ries LAG, et al. SEER Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute; 2006;
  2. Yde CW, et al. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Anticancer Drugs. 2009;20:723–735
  3. Leonessa F, et al. Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies. Cancer Res. 1994;54:441–447
  4. Smith IC, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J. Clin. Oncol. 2002;20:1456–1466
  5. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277:665–667
  6. Ahmad NS, et al. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 2005;32:761–770
  7. Mazlan M, et al. Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J. Neurol. Sci. 2006;243:5–12
  8. Agarwal MK, et al. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle. 2004;3:205–211
  9. Eitsuka T, Nakagawa K, Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem. Biophys. Res. Commun. 2006;348:170–175
  10. Kumar KS, et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci. 2006;78:2099–2104
  11. McAnally JA, et al. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp. Biol. Med. (Maywood). 2007;232:523–531
  12. Nesaretnam K, et al. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids. 2004;39:459–467
  13. Sylvester PW, Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J. Clin. Nutr. 2005;14:366–373
  14. Sen CK, et al. Tocotrienols: the emerging face of natural vitamin E. Vitam. Horm. 2007;76:203–261
  15. Yap WN, et al. Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br. J. Cancer. 2008;99:1832–1841
  16. Chang PN, et al. Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr. Cancer. 2009;61:357–366
  17. Samant GV, Sylvester PW. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Proliferat. 2006;39:563–574
  18. Ahn KS, et al. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 2007;282:809–820
  19. Ling MT, et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis. 2005;26:1668–1676
  20. Jacobs L. Process for the Production of Tocotrienols. USA: Archer–Daniels–Midland Company; 2002;
  21. Albini A, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987;47:3239–3245
  22. Chu Q, et al. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis. 2006;27:2180–2189
  23. Nagaraja GM, et al. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene. 2006;25:2328–2338
  24. Patel NM, et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene. 2000;19:4159–4169
  25. Fong S, et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. USA. 2003;100:13543–13548
  26. Payne SL, et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 2005;65:11429–11436
  27. Gautschi O, et al. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res. 2008;68:2250–2258
  28. Liu Y, et al. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 1995;270:8377–8380
  29. Miglietta A, et al. Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett. 2006;234:149–157
  30. Azzam DG, et al. ERK/MAPK regulation of the androgen responsiveness of breast cancer cells. Adv. Exp. Med. Biol. 2008;617:429–435
  31. Mirzoeva OK, et al. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. Cancer Res. 2009;69:565–572
  32. Saha B, et al. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res. 2007;27:3903–3908
  33. Jeschke U, et al. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Anticancer Res. 2007;27:1969–1974
  34. Morton RA, et al. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 1993;53:3585–3590
  35. Turashvili G, et al. Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer. Cesk. Patol. 2007;43:87–92
  36. van de Wetering M, et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res. 2001;61:278–284
  37. Cano A, et al. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000;2:76–83
  38. Vesuna F, et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun. 2008;367:235–241
  39. Howard EW, et al. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. Clin. Cancer Res. 2007;13:1847–1856
  40. Laux MT, et al. Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. J. Altern. Complement Med. 2004;10:235–239
  41. Qureshi AA, et al. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J. Nutr. 1996;126:389–394
  42. Dawson DA, Rinaldi AC, Poch G. Biochemical and toxicological evaluation of agent–cofactor reactivity as a mechanism of action for osteolathyrism. Toxicology. 2002;177:267–284
  43. Singh J, et al. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 2002;21:1812–1822
  44. Lin CQ, et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 2000;60:1332–1340
  45. Schoppmann SF, et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer. 2003;104:677–682
  46. Erler JT, et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006;440:1222–1226
  47. Yu W, et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer. 1999;33:26–32
  48. Takahashi K, Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem. Pharmacol. 2004;67:315–324
  49. Sylvester PW, Shah SJ. Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front. Biosci. 2005;10:699–709
  50. Nesaretnam K, et al. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids. 1998;33:461–469
  51. Nesaretnam K, et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids. 1995;30:1139–1143
  52. Nesaretnam K, Dorasamy S, Darbre PD. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int. J. Food Sci. Nutr. 2000;51(Suppl):S95–S103
  53. Nesaretnam K, et al. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. NY Acad. Sci. 2004;1031:143–157
  54. Guthrie N, et al. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 1997;127:544S–548S
  55. Elangovan S, Hsieh TC, Wu JM. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res. 2008;28:2641–2647
  56. Sun W, et al. Gamma-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br. J. Nutr. 2008;99:1247–1254
  57. He L, et al. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 1997;127:668–674
  58. Wada S, et al. Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett. 2005;229:181–191
  59. Qureshi AA, et al. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem. 2000;48:3130–3140
  60. McIntyre BS, et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 2000;224:292–301
  61. Zhang X, et al. Inactivation of Id-1 in prostate cancer cells: a potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int. J. Cancer. 2006;118:2072–2081
  62. Kirschmann DA, et al. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 2002;62:4478–4483
  63. Khanna S, et al. Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic. Biol. Med. 2005;39:1310–1319
  64. Patel V, et al. Natural vitamin E alpha-tocotrienol: retention in vital organs in response to long-term oral supplementation and withdrawal. Free Radic. Res. 2006;40:763–771

PII: S0304-3835(09)00634-X

doi: 10.1016/j.canlet.2009.10.012

Cancer Letters
Volume 291, Issue 2 , Pages 187-199 , 28 May 2010

Article Tools

* Image Usage & Resolution